Generated by GPT-5-mini| European School of Oncology | |
|---|---|
| Name | European School of Oncology |
| Formation | 1982 |
| Founder | Gianni Bonadonna (founder) |
| Type | Non-profit organization |
| Headquarters | Milan, Italy |
| Region served | Europe, global |
| Focus | Oncology education, cancer research |
European School of Oncology is an international non-profit institution established to advance oncology education and professional development. It was founded to provide continuing medical education for clinicians and researchers across Europe and beyond, bridging clinical practice, translational research, and policy debates. The institution has engaged with major hospitals, universities, and cancer centers to deliver courses, fellowships, and symposia that connect practitioners from diverse health systems.
The organization was created in 1982 by oncologists and administrators linked to institutions such as San Raffaele Hospital, Humanitas Research Hospital, European Organization for Research and Treatment of Cancer, Istituto Nazionale dei Tumori, and advocates from World Health Organization, Union for International Cancer Control, and philanthropic entities. Early collaborations involved clinicians from Istituto Europeo di Oncologia, pathologists connected to Royal Marsden Hospital, and researchers associated with Institut Gustave Roussy and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Over decades it has organized events drawing faculty from Memorial Sloan Kettering Cancer Center, Mayo Clinic, MD Anderson Cancer Center, Institut Curie, and university departments at University of Oxford, University of Cambridge, Karolinska Institutet, University of Paris, and University of Milan.
The mission emphasizes improving patient care through education involving stakeholders from European Commission, Council of Europe, and national ministries tied to Ministry of Health (Italy), alongside clinical networks like European Society for Medical Oncology, European Cancer Organisation, and specialty societies including International Association for the Study of Lung Cancer, European LeukemiaNet, and European Society of Surgical Oncology. Activities include postgraduate courses, workshops with faculty from Johns Hopkins Hospital, Cleveland Clinic, and Dana-Farber Cancer Institute, multidisciplinary tumor board simulations, and policy forums engaging representatives from European Parliament, Organisation for Economic Co-operation and Development, and patient groups linked to European Patient Forum.
Programs range from introductory modules for trainees affiliated with Università degli Studi di Milano, Sapienza University of Rome, and University of Barcelona to advanced masters and short courses utilizing faculty from University College London, Heidelberg University Hospital, and Ghent University Hospital. Fellowships connect trainees with mentors at Peter MacCallum Cancer Centre, Vall d'Hebron University Hospital, and University Hospital Zurich; hands-on workshops include surgical training influenced by techniques from Royal College of Surgeons of England and radiotherapy modules aligned with guidelines from European Society for Radiotherapy and Oncology. The curriculum incorporates case-based learning drawing on protocols from European Medicines Agency, clinical trial design methods from National Cancer Institute (United States), and ethics discussions informed by precedents like Nuremberg Code.
The institution administers grants and supports investigator-initiated studies through partnerships with funding bodies such as European Research Council, Horizon 2020, Fondazione Cariplo, and charitable trusts similar to Wellcome Trust and Gordon and Betty Moore Foundation. Grant programs have funded translational projects collaborating with laboratories at Max Planck Institute for Molecular Biomedicine, Francis Crick Institute, and Barcelona Supercomputing Center for bioinformatics analyses. Research priorities often mirror agendas set by consortia including Cancer Core Europe, Transcan, and networks like European Thoracic Oncology Platform.
Educational materials include course syllabi, e-learning modules, and review series produced in conjunction with journals and publishers such as The Lancet Oncology, Journal of Clinical Oncology, Nature Reviews Cancer, European Journal of Cancer, and Annals of Oncology. Resources have been cited alongside guidelines from organizations like National Comprehensive Cancer Network, European Society for Medical Oncology, and position papers from World Health Organization tumor control programs. Multimedia libraries compile lectures featuring experts associated with Paul O'Gorman Leprosy Research Laboratory, Sloan Kettering Institute, and author groups linked to landmark trials such as those reported by International Breast Cancer Study Group.
Governance structures include a scientific advisory board composed of clinicians and researchers affiliated with Imperial College London, Karolinska University Hospital, Institute of Cancer Research (UK), and academic leaders from University of Vienna and KU Leuven. Funding streams combine educational fees, unrestricted grants from philanthropic foundations like Fondazione Veronesi and corporate sponsorships from healthcare companies regulated by European Medicines Agency, with oversight to avoid conflicts of interest through policies modeled on standards from Committee on Publication Ethics and audit practices akin to European Court of Auditors.
The organization has influenced practice through alumni working at institutions including St. Bartholomew's Hospital, University Hospital Leuven, Charité – Universitätsmedizin Berlin, Addenbrooke's Hospital, and cancer centers such as Royal Marsden Hospital and Gustave Roussy. Collaborations extend to global partners like American Society of Clinical Oncology, Asian Pacific Organization for Cancer Prevention, Pan American Health Organization, and research networks including European Genome-phenome Archive initiatives. Its educational footprint is reflected in joint programs with universities and professional societies that shape curricula and consensus statements appearing alongside guidelines from NICE, European Centre for Disease Prevention and Control, and multinational clinical trial consortia such as EORTC.
Category:Medical education organizations